Picture of Castle Biosciences logo

CSTL — Castle Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Castle Biosciences Inc reports results for the quarter ended in June - Earnings Summary

* Castle Biosciences Inc  CSTL.OQ  reported quarterly
adjusted
earnings of 31 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -70 cents.  The mean expectation of
nine analysts for the quarter was for a loss of 27 cents per
share. Wall Street expected results to range from -46 cents
to -10 cents per share.
    * Revenue rose 73.5% to $87.00 million from a year ago;
analysts
expected $69.34 million. 
    * Castle Biosciences Inc's reported EPS for the quarter was
31
cents​.
    * The company reported quarterly net income of $8.92
million.
    * Castle Biosciences Inc shares had risen by 2.3% this
quarter and
gained 3.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 8.5%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "strong buy"

Wall Street's median 12-month price target for Castle
Biosciences Inc is $34.00 
This summary was machine generated from LSEG data August 5 at
09:22 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.27          0.31           Beat
 Mar. 31 2024      -0.33          -0.09          Beat
 Dec. 31 2023      -0.54          -0.10          Beat
 Sep. 30 2023      -0.76          -0.26          Beat

Recent news on Castle Biosciences

See all news